DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr | ₹-83 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-269 Cr |
Mar2023 | ₹-2,707 Cr |
Mar2022 | ₹-2,195 Cr |
Mar2021 | ₹75 Cr |
Mar2020 | ₹-83 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-269 Cr | Negative | |
Mar2023 | ₹-2,707 Cr | Negative | |
Mar2022 | ₹-2,195 Cr | Negative | |
Mar2021 | ₹75 Cr | Positive | |
Mar2020 | ₹-83 Cr | - |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹181,888.7 Cr | 3.7% | 3% | 46.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,017.0 Cr | 0.9% | -0.1% | 10.9% | Stock Analytics | |
CIPLA | ₹122,451.0 Cr | 0.2% | 2.8% | 1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,620.0 Cr | 7.3% | 7.4% | 19.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,572.0 Cr | -4% | 2.6% | 7.2% | Stock Analytics | |
MANKIND PHARMA | ₹94,465.4 Cr | 0.6% | -6.1% | 9.3% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 3.7% |
3% |
46.5% |
SENSEX | 2% |
2.8% |
6.4% |
You may also like the below Video Courses